Stock Screener App

Gratuito -

Installare

4.16

1.96% 0.08

after-market

Dopo l'orario di chiusura: 4.16

Arbutus Biopharma Corp (ABUS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Arbutus Biopharma Corp Borsa (ABUS) Ultime notizie

Traders Buy Large Volume of Call Options on Arbutus Biopharma (NASDAQ:ABUS) - MarketBeat

Aug Drivers: Can Arbutus Biopharma Corporation ride the EV waveQuarterly Investment Review & Consistent Return Strategy Ideas - baoquankhu1.vn

Arbutus Biopharma (NASDAQ:ABUS) Stock Passes Above 200-Day Moving AverageHere's What Happened - MarketBeat

Aug Closing: Should I buy Arbutus Biopharma Corporation stock nowJuly 2025 Volume & Weekly High Momentum Picks - baoquankhu1.vn

Arbutus Biopharma (ABUS) Patent Invalidated by European Patent O - GuruFocus

Arbutus Biopharma (ABUS) Faces Patent Revocation in Europe - GuruFocus

ABUS Stock Tumbles on European Patent Revocation - StocksToTrade

Arbutus Biopharma (ABUS) Shares Drop Amid Patent Revocation - GuruFocus

Market Dynamics Cause Shifts for Arbutus Biopharma - StocksToTrade

Arbutus Biopharma (ABUS) Patent Revocation Leads to 18% Stock Crash - Intellectia AI

Arbutus Biopharma (NASDAQ:ABUS) Shares Gap DownHere's Why - MarketBeat

Arbutus (ABUS) upgraded to buy: Here's what you should know - MSN

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Arbutus Biopharma Shares Fall 19% On European Patent Revocation - Nasdaq

Arbutus Biopharma (ABUS) Patent Revocation Leads to 14% Pre-Market Drop - Intellectia AI

European Patent Office revokes Arbutus Biopharma patent following appeal - Investing.com

Arbutus Biopharma CorpEPO revokes Arbutus Biopharma's European patent EP 2279254SEC filing - marketscreener.com

Arbutus falls as patent dispute with Moderna hits EU snag - Seeking Alpha

Weekly Trades: Will Arbutus Biopharma Corporation stock gain from lower inflationTrade Signal Summary & Stock Market Timing Techniques - Bộ Nội Vụ

Arbutus Biopharma (NASDAQ:ABUS) Stock Price Crosses Above 200 Day Moving AverageHere's What Happened - MarketBeat

Arbutus (ABUS) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

How sustainable is Arbutus Biopharma Corporation stock dividend payoutBear Alert & Safe Entry Momentum Stock Tips - Улправда

Why Arbutus Biopharma Corporation stock is popular among millennialsQuarterly Portfolio Summary & Long-Term Growth Plans - Улправда

New Highs: Why Arbutus Biopharma Corporation stock is popular among millennialsEarnings Miss & Growth-Oriented Investment Plans - Улправда

What is the fair value of Arbutus Biopharma Corporation stock nowWeekly Trading Summary & Weekly Momentum Picks - Улправда

Will Arbutus Biopharma Corporation stock deliver shareholder valueWeekly Market Report & Fast Entry Momentum Alerts - Улправда

How Arbutus Biopharma Corporation stock reacts to Fed rate cutsQuarterly Portfolio Summary & Weekly High Momentum Picks - Улправда

Is Arbutus Biopharma Corporation stock supported by strong fundamentals2025 Pullback Review & Consistent Income Trade Recommendations - Улправда

Why Arbutus Biopharma Corporation stock is seen as undervaluedProduct Launch & Low Drawdown Trading Strategies - Улправда

Hepatitis B Market to Witness Promising Upswing by 2034, DelveInsight Forecasts | Arbutus Biopharma, GSK/Ionis Pharma, Vir Biotech, Dong-A ST Co., Ltd., Barinthus Biotherapeutics, GC Biopharma Corp - The Globe and Mail

Hepatitis B Market to Witness Promising Upswing by 2034, - openPR.com

Arbutus Biopharma's CFO David Hastings sells shares worth $72,826 - MSN

Arbutus Biopharma (NASDAQ:ABUS) Shares Up 6%Still a Buy? - MarketBeat

Pharma Patent Trials Loom in 2026 for Wegovy, Covid-Vaccine Tech - Mintz

Arbutus Biopharma (NASDAQ:ABUS) Share Price Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Arbutus Biopharma (NASDAQ:ABUS) Share Price Passes Above Two Hundred Day Moving Average – Time to Sell? - Defense World

Why Arbutus Biopharma Corporation stock is rated strong buyEarnings Recap Summary & Fast Moving Market Watchlists - Улправда

ABUS (Arbutus Biopharma) OCF Margin % : -1,099.62% (As of Sep. 2025) - GuruFocus

Is Arbutus Biopharma Corporation stock ready for breakoutCEO Change & Reliable Entry Point Alerts - ulpravda.ru

Does Arbutus Biopharma Corporation stock trade at a discount to peersPortfolio Update Report & Weekly Watchlist of Top Performers - Улправда

Arbutus Biopharma (NASDAQ:ABUS) Stock Price Down 6.4%What's Next? - MarketBeat

Arbutus Biopharma (NASDAQ:ABUS) Trading Up 6.6%Should You Buy? - MarketBeat

BlackBarn Capital Partners LP Boosts Stock Position in Arbutus Biopharma Corporation $ABUS - MarketBeat

A Look at Arbutus Biopharma Corp (ABUS) Shares in the Recent Past Indicates Growth - setenews.com

Arbutus Biopharma Corp Discusses Ongoing Patent Litigation - TradingView — Track All Markets

[8-K] Arbutus Biopharma Corp Reports Material Event | ABUS SEC FilingForm 8-K - Stock Titan

Arbutus Biopharma Corporation $ABUS Shares Purchased by Two Seas Capital LP - MarketBeat

New Haven biotech names new CFO - hartfordbusiness.com

The time has not yet come to remove your chips from the table: Arbutus Biopharma Corp (ABUS) - setenews.com

Why global investors buy Arbutus Biopharma Corporation (I9DN) stockWeekly Trend Summary & Community Supported Trade Ideas - Newser

Can Arbutus Biopharma Corporation (I9DN) stock hold up in economic slowdown2025 Year in Review & Real-Time Stock Entry Alerts - Newser

Is Arbutus Biopharma Corporation (I9DN) stock a buy for dividend portfoliosPortfolio Value Report & Fast Moving Stock Trade Plans - Newser

Arbutus Biopharma (ABUS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

How Arbutus Biopharma Corporation (I9DN) stock trades after earningsJuly 2025 Short Interest & Capital Efficiency Focused Strategies - Newser

Why Arbutus Biopharma Corporation (I9DN) stock could outperform next yearJuly 2025 Short Interest & Safe Capital Allocation Plans - Newser

There is no way Arbutus Biopharma Corp (ABUS) can keep these numbers up - setenews.com

Arbutus Biopharma (NASDAQ:ABUS) Stock Price Crosses Above 200 Day Moving Average – Here’s What Happened - Defense World

How Arbutus Biopharma Corporation (I9DN) stock reacts to new regulationsEarnings Risk Summary & Weekly Setup with High ROI Potential - newser.com

A look into Arbutus Biopharma Corp (ABUS)’s deeper side - Setenews

Why Arbutus Biopharma Corporation stock is trending among retail tradersJuly 2025 Volume & Daily Growth Stock Tips - newser.com

Arbutus Reports Major Advances in HBV Candidate as Litigation Against Moderna, Pfizer Builds Toward Trial - MyChesCo

RVMD

$99.82

2.09%

INCY

$103.47

0.87%

GMAB

$34.40

2.78%

BNTX

$119.34

1.14%

INSM

$162.64

1.83%

ONC

$336.16

0.48%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters